fasudil has been researched along with Infant, Newborn, Diseases in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lopez, NC | 1 |
| Ebensperger, G | 1 |
| Herrera, EA | 1 |
| Reyes, RV | 1 |
| Calaf, G | 1 |
| Cabello, G | 1 |
| Moraga, FA | 1 |
| Beñaldo, FA | 1 |
| Diaz, M | 1 |
| Parer, JT | 1 |
| Llanos, AJ | 1 |
1 other study available for fasudil and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Role of the RhoA/ROCK pathway in high-altitude associated neonatal pulmonary hypertension in lambs.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Altitude Sickness; Animals; Animals, Newborn; Humans; | 2016 |